MODELING FUNCTIONAL DECLINE OVER TIME IN SPORADIC INCLUSION BODY MYOSITIS

被引:15
作者
Alfano, Lindsay N. [1 ]
Yin, Han [2 ]
Dvorchik, Igor [2 ]
Maus, Elizabeth G. [1 ]
Flanigan, Kevin M. [1 ]
Mendell, Jerry R. [1 ]
Lowes, Linda P. [1 ]
机构
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, 700 Childrens Dr,Room AB1042, Columbus, OH 43205 USA
[2] Nationwide Childrens Hosp Biostat Core, Res Inst, Columbus, OH USA
关键词
disease progression; function; natural history; logistic model; sporadic inclusion body myositis; DISEASE PROGRESSION; STRENGTH; THERAPY;
D O I
10.1002/mus.25373
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The ability to individualize recommendations or expectations of disease progression based on a patient's unique characteristics has merit for use in sporadic inclusion body myositis (sIBM). Methods: Fifty-five subjects with sIBM completed a battery of strength and functional outcomes at 2 study visits. These were used to develop mathematical models of disease progression in patients with sIBM for use in clinical and research settings. Results: The 6-minute walk test (6MWT) distance declined by an average of 27.5 meters (12%) per year. Significant factors that predict 6MWT were knee extension and plantarflexion strength and body weight, whereas the ability to stand from a chair was impacted by elbow extension strength. Stepping up on a curb was influenced by the patient's age at diagnosis and by knee extension. Statistical models to predict functional decline in sIBM were developed. Conclusion: Statistical models help explain the complex factors that influence decreased walking ability and other functional activities in sIBM.
引用
收藏
页码:526 / 531
页数:6
相关论文
共 19 条
  • [1] Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis
    Allenbach, Yves
    Benveniste, Olivier
    Decostre, Valerie
    Canal, Aurelie
    Eymard, Bruno
    Herson, Serge
    Bloch-Queyrat, Coralie
    Hogrel, Jean-Yves
    [J]. NEUROMUSCULAR DISORDERS, 2012, 22 (11) : 980 - 986
  • [2] Long-term observational study of sporadic inclusion body myositis
    Benveniste, Olivier
    Guiguet, Marguerite
    Freebody, Jane
    Dubourg, Odile
    Squier, Waney
    Maisonobe, Thierry
    Stojkovic, Tanya
    Leite, Maria Isabel
    Allenbach, Yves
    Herson, Serge
    Brady, Stefen
    Eymard, Bruno
    Hilton-Jones, David
    [J]. BRAIN, 2011, 134 : 3176 - 3184
  • [3] Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials
    Cortese, A.
    Machado, P.
    Morrow, J.
    Dewar, L.
    Hiscock, A.
    Miller, A.
    Brady, S.
    Hilton-Jones, D.
    Parton, M.
    Hanna, M. G.
    [J]. NEUROMUSCULAR DISORDERS, 2013, 23 (05) : 404 - 412
  • [4] INCLUSION-BODY MYOSITIS AND MYOPATHIES
    GRIGGS, RC
    ASKANAS, V
    DIMAURO, S
    ENGEL, A
    KARPATI, G
    MENDELL, JR
    ROWLAND, LP
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (05) : 705 - 713
  • [5] Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI [10.1016/j.nmd.2009.11.003, 10.1016/j.nmd.2010.07.087]
  • [6] Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials
    Hogrel, Jean-Yves
    Allenbach, Yves
    Canal, Aurelie
    Leroux, Gaelle
    Ollivier, Gwenn
    Mariampillai, Kuberaka
    Servais, Laurent
    Herson, Serge
    Decostre, Valerie
    Benveniste, Olivier
    [J]. NEUROMUSCULAR DISORDERS, 2014, 24 (07) : 604 - 610
  • [7] SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
    Kobayashi, Dione T.
    Shi, Jing
    Stephen, Laurie
    Ballard, Karri L.
    Dewey, Ruth
    Mapes, James
    Chung, Brett
    McCarthy, Kathleen
    Swoboda, Kathryn J.
    Crawford, Thomas O.
    Li, Rebecca
    Plasterer, Thomas
    Joyce, Cynthia
    Chung, Wendy K.
    Kaufmann, Petra
    Darras, Basil T.
    Finkel, Richard S.
    Sproule, Douglas M.
    Martens, William B.
    McDermott, Michael P.
    De Vivo, Darryl C.
    Walker, Michael G.
    Chen, Karen S.
    [J]. PLOS ONE, 2013, 8 (04):
  • [8] Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
    Kota, Janaiah
    Handy, Chalonda R.
    Haidet, Amanda M.
    Montgomery, Chrystal L.
    Eagle, Amy
    Rodino-Klapac, Louise R.
    Tucker, Danielle
    Shilling, Christopher J.
    Therlfall, Walter R.
    Walker, Christopher M.
    Weisbrode, Steven E.
    Janssen, Paul M. L.
    Clark, K. Reed
    Sahenk, Zarife
    Mendell, Jerry R.
    Kaspar, Brian K.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (06)
  • [9] Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis
    Lowes, Linda Pax
    Alfano, Lindsay
    Viollet, Laurence
    Rosales, Xiomara Quintero
    Sahenk, Zarife
    Kaspar, Brian K.
    Clark, K. Reed
    Flanigan, Kevin M.
    Mendell, Jerry R.
    McDermott, Michael P.
    [J]. MUSCLE & NERVE, 2012, 45 (02) : 163 - 168
  • [10] Gene therapy for muscular dystrophy: Lessons learned and path forward
    Mendell, Jerry R.
    Rodino-Klapac, Louise
    Sahenk, Zarife
    Malik, Vinod
    Kaspar, Brian K.
    Walker, Christopher M.
    Clark, K. Reed
    [J]. NEUROSCIENCE LETTERS, 2012, 527 (02) : 90 - 99